Diagnostic and therapeutic care pathway for fibromyalgia

P. Sarzi-Puttini, V. Giorgi, F. Atzeni, R. Gorla, E. Kosek, E. H. Choy, L. Bazzichi, W. Häuser, J. N. Ablin, V. Aloush, D. Buskila, H. Amital, J. A.P. Da Silva, S. Perrot, B. Morlion, E. Polati, V. Schweiger, S. Coaccioli, G. Varrassi, M. Di FrancoR. Torta, K. M.Øien Forseth, K. Mannerkorpi, F. Salaffi, M. Di Carlo, G. Cassisi, A. Batticciotto

    Research output: Contribution to journalArticlepeer-review

    8 Scopus citations


    Early diagnosis and timely and appropriate treatments positively influence the history of fibromyalgia syndrome (FM), with favourable repercussions at clinical, psychological, social and economic levels. Notwithstanding, there are still significant problems with timeliness of diagnosis, access to pharmacological therapies – particularly to innovative ones – and appropriate and effective taking in charge of patients. All the aforementioned factors have a great impact on FM patients’ quality of life. Indeed, even though the World Health Organisation recognised FM as a chronic condition in the International Classification of Diseases 10th edition (ICD-10), many countries still fail to recognise the syndrome, and this negatively influences the capability to appropriately protect and care for patients. This is the case in several European Countries. In Italy, a few Regions have started to put in place precise indications for people suffering from FM, aiming at the implementation of diagnostic-therapeutic pathways. The Diagnostic-Therapeutic Care Pathway (DTCP) provides an important tool to meet the needs of patients suffering from chronic diseases. They present the organisation of an integrated assistance network. This includes a seamless path for disease prevention, diagnosis and treatment, by means of cooperation among physicians and other healthcare professionals.

    Original languageEnglish
    JournalClinical and Experimental Rheumatology
    Issue number3
    StatePublished - 1 Jan 2021


    • Chronic disease
    • Diagnostic-therapeutic care pathway
    • Fibromyalgia
    • Health policies
    • Treatment

    ASJC Scopus subject areas

    • Rheumatology
    • Immunology and Allergy
    • Immunology


    Dive into the research topics of 'Diagnostic and therapeutic care pathway for fibromyalgia'. Together they form a unique fingerprint.

    Cite this